Clinical Trial Update: Therapy of Ventilator-associated Tracheobronchitis Caused by Gram Negative Bacteria With Nebulized Colistin [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating nebulized colistin for ventilator-associated tracheobronchitis caused by Gram-negative bacteria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Ventilator-associated Tracheobronchitis

Drugs mentioned

• Colistin (colistin)

Snippet

Sponsor: Mahidol University | Conditions: Bronchitis | Phase 3 | Status: UNKNOWN